01530.HK
3SBio Inc.
HKSE · Healthcare · Biotechnology · CN
HKD 16.24
−0.31%Margins
Gross margin
89.7%
EBITDA margin
52.4%
EBIT margin
49.4%
Net margin
39.5%
FCF margin
34.0%
38.6%
Return on equity
29.8%
Return on assets
47.1%
Return on invested capital
0.75x
Asset turnover
HKD 11.3B
Cash from operations
HKD 8.46
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026